SCHEMBL30982470

SCHEMBL30982470

CCCCCCCC/C=C\CCCCCCCCn1ccc(=O)c(O)c1CC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 3/20 0.47
▸ FAAH O00519 2/20 0.43
▸ PSMB11 A5LHX3 2/20 0.38
▸ PSMA7 O14818 2/20 0.38
▸ PSMB1 P20618 2/20 0.38
▸ PSMA1 P25786 2/20 0.38
▸ PSMA2 P25787 2/20 0.38
▸ PSMA3 P25788 2/20 0.38
▸ PSMA4 P25789 2/20 0.38
▸ PSMB8 P28062 2/20 0.38
▸ PSMB9 P28065 2/20 0.38
▸ PSMA5 P28066 2/20 0.38
▸ PSMB4 P28070 2/20 0.38
▸ PSMB6 P28072 2/20 0.38
▸ PSMB5 P28074 2/20 0.38
▸ PSMB10 P40306 2/20 0.38
▸ PSMB3 P49720 2/20 0.38
▸ PSMB2 P49721 2/20 0.38
▸ PSMA6 P60900 2/20 0.38
▸ PSMA8 Q8TAA3 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30982401 0.92 KDM4E (0.42) MGLLFAAHAPPHRH3MAOB
SCHEMBL30982990 0.92 KDM4E (0.42) MGLLFAAHAPPHRH3MAOB
SCHEMBL30982374 0.92 KDM4E (0.42) MGLLFAAHAPPHRH3MAOB
SCHEMBL31041858 0.88 APP (0.49) MGLLFAAHPSMB11PSMA7PSMB1
SCHEMBL9479895 0.80 KDM4E (0.42) APPHRH3MAOBKDM4EMAPT
SCHEMBL30982683 0.80 PSMB11 (0.39) MGLLFAAHPSMB11PSMA7PSMB1
SCHEMBL5515462 0.80 KDM4E (0.47) APPHRH3MAOBKDM4EHTT
Hydrochloric Acid SCHEMBL9478707 0.79 APP (0.41) APPHRH3MAOBKDM4EMAPT
SCHEMBL30982928 0.79 APP (0.56) APPHRH3MAOBKDM4EMAPT
SCHEMBL30982553 0.79 APP (0.56) APPHRH3MAOBKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 — — US disclosed
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 — — US disclosed
US-12503666-B2 Multipurpose oxypyridinones and their functional use-2 INFINEUM INTERNATIONAL LIMITED (US) 2025-12-23 — — US disclosed
US-20240294840-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240294842-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-4 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240294841-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-3 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240287405-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE - 1 INFINEUM INTERNATIONAL LIMITED (US) 2024-08-29 — — US disclosed
EP-4417673-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417674-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417672-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417675-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
CN-118516151-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516152-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516153-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516154-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294840-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 SIGMAR1, OXGR1, OPRM1 MGLL 1606/4885FAAH 1526/4885PSMB11 4456/4885
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 PHOSPHO1, SIGMAR1, SGMS1 MGLL 7/4885FAAH 824/4885PSMB11 4065/4885
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 SIGMAR1, PHOSPHO1, SGMS1 MGLL 11/4885FAAH 1237/4885PSMB11 3670/4885
US-12503666-B2 Multipurpose oxypyridinones and their functional use-2 SIGMAR1, OXGR1, OPRM1 MGLL 1606/4885FAAH 1526/4885PSMB11 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback